Qiagen NV (XTER:QIA) Margin of Safety % (DCF FCF Based): N/A (As of Jun. 30, 2026)


XTER:QIA Qiagen NV XTER:QIA
71 GF Score
Price €34.57
GF Value €45.90
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Qiagen NV Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Qiagen NV's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

XTER:QIA vs TWST, CRL, BLLN: Margin of Safety % (DCF FCF Based) Comparison

For the Diagnostics & Research subindustry, Qiagen NV's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Qiagen NV Margin of Safety % (DCF FCF Based) vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Qiagen NV's Margin of Safety % (DCF FCF Based) falls into.


XTER:QIA
71GF Score
Qiagen NV XTER:QIA
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Qiagen NV (XTER:QIA) Overvalued in 2026?

Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued. The current stock price of €34.57 is trading 24.7% below its estimated GF Value™ of €45.90. GuruFocus considers Qiagen NV to be Modestly Undervalued.

Key valuation signals for XTER:QIA:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: €45.90 vs. price of €34.57 (24.7% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the XTER:QIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Qiagen NV Business Description

Address Hulsterweg 82, Venlo, LI, NLD, 5912 PL
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
71GF Score

Get the complete analysis for XTER:QIA

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€34.57
Price
€45.90
GF Value